Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.44+0.06 (+15.11%)
Close on Nov 18, 2026Market cap $56.14MP/E –Yield –
Oncolytics Biotech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2024 it was -C$34.98M. The highest annual figure on record is -C$13.92M in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -C$34.98M | – |
| FY2023 | Dec 31, 2023 | -C$33.79M | – |
| FY2022 | Dec 31, 2022 | -C$26.92M | – |
| FY2021 | Dec 31, 2021 | -C$26.24M | – |
| FY2020 | Dec 31, 2020 | -C$25.46M | – |
| FY2019 | Dec 31, 2019 | -C$20.38M | – |
| FY2018 | Dec 31, 2018 | -C$17.27M | – |
| FY2017 | Dec 31, 2017 | -C$15.61M | – |
| FY2016 | Dec 31, 2016 | -C$15.29M | – |
| FY2015 | Dec 31, 2015 | -C$13.92M | – |
See a number that looks wrong?